The downgrade comes after the company reported full-year revenue that fell 4% below market expectations, reflecting an underperformance in the second half of the year.
(Alliance News) - Alliance Pharma PLC on Friday said it expects to report 2024 profit broadly in line with the year before, despite a decline in annual revenue.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback